NEW YORK (Reuters Health) - Therapy with valacyclovir (Valtrex, GlaxoSmithKline), started within three months of infection with either herpes simplex virus type 1 (HSV-1) or HSV type 2 (HSV-2), ...

May 19, 2004 (Boston) — Valacyclovir is equally as effective as ganciclovir in preventing cytomegalovirus (CMV) in renal transplantation, and it may be more cost-effective as well, researchers ...

Feb. 23, 2005 (New Orleans) — One day of high-dose oral valacyclovir treatment significantly decreases the duration of virus shedding that occurs with recurrent herpes labialis and may reduce the ...

May 25, 2010 -- Sandoz today announced the introduction in the US of valacyclovir hydrochloride (HCl) tablets, a generic equivalent of Valtrex. Valacyclovir HCl tablets are indicated for treatment of ...

Anti-herpetic agents reduce recurrence of herpes simplex-2 (HSV-2) symptoms but do not completely block subclinical shedding of virus, even at high doses, researchers reported. In three complementary ...

Getting your Trinity Audio player ready... Q: I’m a 64-year-old female with shingles. I have severe pain in the breastbone and back and a small rash under my breast. I cannot tolerate Valtrex, which ...

NEW YORK (Reuters Health) - Recurrent outbreaks of herpes simplex virus 2 (HSV2), or "genital herpes," can be effectively treated with a one-day course of valacyclovir (sold under the trade name ...

Q. I had the flu in March 2020 and then came down with another infection. I think it was COVID-19, but there were no home tests at the time. Even though my case was no worse than the flu, it left me ...

An international team of researchers finds that taking a single daily dose of an approved antiviral drug known as valacyclovir can reduce the transmission of genital herpes to uninfected partners by ...

Generic Valtrex valacyclovir is an antiviral drug that is used to treat infections caused by certain types of viruses. In children 12 years or older it is used to treat cold sores around the mouth ...

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, has announced the positive results from a pivotal ...